Skip to main content
SpringerLink
Log in

Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Twenty-three patients with aplastic anemia (18/23 with severe aplastic anemia) were treated with an immunosuppressive regimen consisting of cyclosporin A (CsA) and methylprednisolone (MP) (n=7) or CsA, MP, and antithymocyte globulin (ATG;n=16). Nineteen patients are alive with a follow-up of 4 to 25 months; three patients died of infections and one of a gastrointestinal hemorrhage. Within 3 months, improvement of hematopoiesis was seen in 14 patients (61%). First signs of a response after 23 to 88 days were followed by complete remission in eight patients, partial remission in three patients, and minimal improvement in three patients. Two of the patients with only minimal improvement were treated with a second course of immunosuppression and reached a complete remission and partial remission. Interestingly, remission proved to be dependent on the continued administration of CsA in four of five patients with partial or complete remission who could be evaluated up to now. Thus, CsA must have been effective in the induction and/or maintenance of remission in three patients. This observation is a very strong argument for the role of T cells in the pathogenesis of at least some cases of aplastic anemia and warrants further evaluation of the role of CsA in the treatment of aplastic anemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ALG:

Antilymphocyte globulin

ATG:

Antithymocyte globulin

CR:

Complete remission

CsA:

Cyclosporin A

MI:

Minimal Improvement

MP:

Methylprednisolone

NR:

No response

PR:

Partial remission

SAA:

Severe aplastic anemia

SGPT:

Serum alanine aminotransferase

References

  1. Bacigalupo A, Podesta M, van Lint MT, Vimercati R, Cerri R, Rossi E, Risso M, Carella A, Santini G, Damasio E, Giordano D, Marmont A (1981) Severe aplastic anemia: correlation of in vitro tests with clinical response to immunosuppression in 20 patients. Br J Haematol 47:423–433

    Google Scholar 

  2. Beveridge T, Krupp P, McKibbin C (1984) Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy. Lancet I:788

    Google Scholar 

  3. Bunjes D, Hardt C, Roellinghoff M, Wagner H (1981) Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 11:657–661

    Google Scholar 

  4. Camitta BM (1984) A controlled prospective trial of anti-thoracic duct lymphocyte globulin (ATDLG) for treatment of severe aplastic anemia. Prog Clin Biol Res 148:239–247

    Google Scholar 

  5. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JR, Santos G, Gordon-Smith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504–514

    Google Scholar 

  6. Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia. A prospective randomized trial. N Engl J Med 308:113–118

    Google Scholar 

  7. Doney KC, Torok-Storb B, Dahlberg S, Buckner CD, Martin D, Hansen JA, Thomas ED, Storb R (1984) Immunosuppressive therapy of severe aplastic anemia. Prog Clin Biol Res 148:259–270

    Google Scholar 

  8. Finlay JL, Toretsky J, Hoffman R, Bruno E, Shahidi NT (1984) Cyclosporine A (CyA) in refractory aplastic anemia (AA). Blood 64 [Suppl 1]:104(abstract)

    Google Scholar 

  9. Gascon P, Zoumbos NC, Scale G, Djeu ZY, Moore JG, Young NS (1985) Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of anti-thymocyte globulin. Blood 65:407–413

    Google Scholar 

  10. Heimpel H (1979) Stimulation of hematopoiesis in aplastic anemia by hormones and other agents. In: Heimpel H, Gordon-Smith EC, Heit W, Kubanek B (eds) Aplastic anemia: pathophysiology and approaches to therapy. Springer, Berlin, Heidelberg (Haematology and blood transfusion, vol 24, pp 129–137)

    Google Scholar 

  11. Heimpel H, Dietrich M, Erdmann H (1968) Azathioprinbehandlung einer kindlichen Panmyelopathie mit schwerer amegakaryozytaerer Thrombopenie. In: Schlegel B (ed) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Bergmann, Munich, pp 632–635

  12. Hows J, Palmer S, Gordon-Smith EC (1985) Cyclosporin and graft failure following bone marrow transplantation for severe aplastic anemia. Br J Haematol 60:611–617

    Google Scholar 

  13. Jacobs P, Wood L, Martell RW (1985) Cyclosporin A in the treatment of severe acute aplastic anaemia. Br J Haematol 61:267–272

    Google Scholar 

  14. Kalman VK, Klimpel GR (1983) Effects of cyclosporin on the production of various interferons. Transplant Proc 15:2383–2386

    Google Scholar 

  15. Kroenke M, Leonhard WJ, Depper JM, et al. (1984) Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 81:5214–5218

    Google Scholar 

  16. Kupiec-Weglinski JW, Filho MA, Strom TB, Tilney NL (1984) Sparing of suppressor cells: a critical action of cyclosporin. Transplantation 38:97–101

    Google Scholar 

  17. Lafferty KJ, Borel JF, Hodgkin P (1983) Cyclosporin-A (CsA): models for the mechanism of action. Transplant Proc 15:2242–2247

    Google Scholar 

  18. Marsh J, Hows JM, Yin JL, Palmer S, Gordon-Smith EC (1984) Allogeneic bone marrow transplantation for severe aplastic anemia using cyclosporin. Exp Hematol 12 [Suppl 15]:37–38

    Google Scholar 

  19. Miyawaki T, Yachie A, Ohzuki S, Nagaoki T, Tangiguchi N (1983) Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogenstimulated human T cells. J Immunol 130:2737–2741

    Google Scholar 

  20. Orosz CG, Roopenian DC, Widmer MB, Bach FH (1984) Analysis of clonal T cell function. II. Differential blockade of various cloned T cell functions by cyclosporin. Transplantation 36:706–711

    Google Scholar 

  21. Podesta M, Bacigalupo A, Frassoni F (1983) Generation of CFU-C suppressor T cells. VI. Effect of cyclosporin A. Acta Haematol (Basel) 70:163–169

    Google Scholar 

  22. Reem CH, Cook LA, Vilcek J (1983) Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 221:63–65

    Google Scholar 

  23. Seip M, Vidnes J (1985) Cyclosporin A in a case of refractory severe aplastic anemia. Scand J Haematol 34:228–230

    Google Scholar 

  24. Speck B, Gluckmann E, Haak HL, Van Rood JJ (1977) Treatment of aplastic anemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet II:1145–1148

    Google Scholar 

  25. Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K, Fefer A, Goodell B, Mickelson E, Stewart P, Sullivan MS, Witherspoon RP (1983) Factors associated with graft rejection of the HLA-identical bone marrow transplantation for aplastic anemia. Br J Haematol 55:573–582

    Google Scholar 

  26. Stryckmans PA, Debusscher L, Paridaens R, Otten J (1984) Cyclosporin (Cs) for therapy of severe aplastic anemia (SAA) and pure red cell anemia (PRCA). Blood 64 [Suppl 1]:108 (abstract)

    Google Scholar 

  27. White DJG, Plumb AM, Pawelac G, Brons G (1979) Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation 27:55–58

    Google Scholar 

  28. Wisloff F, Godal HC (1985) Cyclosporin in refractory severe aplastic anemia. N Engl J Med 312:1193

    Google Scholar 

  29. Young N, Speck B (1984) Antithymocyte and antilymphocyte globulins: clinical trials and mechanism of action. Prog Clin Biol Res 148:221–226

    Google Scholar 

  30. Zoumbos NC, Djeu J, Young NS (1984) Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133:769–774

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin III, Klinikum der Universität Ulm, Ulm

    N. Frickhofen, W. Heit, A. Raghavachar, F. Porzsolt & H. Heimpel

Authors
  1. N. Frickhofen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Heit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Raghavachar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. F. Porzsolt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Heimpel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frickhofen, N., Heit, W., Raghavachar, A. et al. Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin. Klin Wochenschr 64, 1165–1170 (1986). https://doi.org/10.1007/BF01728454

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01728454

Key words

Search

Navigation